Share on StockTwits

Shares of Endo International PLC (NASDAQ:ENDP) saw a significant drop in short interest in the month of July. As of July 31st, there was short interest totalling 7,356,379 shares, a drop of 10.6% from the July 15th total of 8,230,485 shares, Stock Ratings Network reports. Approximately 4.9% of the shares of the stock are short sold. Based on an average daily trading volume, of 1,534,971 shares, the short-interest ratio is currently 4.8 days.

In other Endo International PLC news, Director Arthur J. Higgins acquired 3,500 shares of the company’s stock in a transaction dated Tuesday, August 5th. The stock was purchased at an average price of $65.65 per share, for a total transaction of $229,775.00. The purchase was disclosed in a filing with the SEC, which is available at this link.

A number of research firms have recently commented on ENDP. Analysts at Zacks reiterated a “neutral” rating on shares of Endo International PLC in a research note on Friday, August 1st. They now have a $70.00 price target on the stock. Separately, analysts at Stifel Nicolaus raised their price target on shares of Endo International PLC from $75.00 to $84.00 in a research note on Friday, August 1st. They now have a “buy” rating on the stock. Finally, analysts at Sterne Agee raised their price target on shares of Endo International PLC from $1.00 to $75.00 in a research note on Thursday, July 31st. One research analyst has rated the stock with a sell rating, eight have given a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company. The stock has an average rating of “Hold” and a consensus target price of $73.60.

Endo International PLC (NASDAQ:ENDP) opened at 62.395 on Thursday. Endo International PLC has a 52 week low of $36.21 and a 52 week high of $82.16. The stock has a 50-day moving average of $67.04 and a 200-day moving average of $68.37. The company’s market cap is $9.576 billion.

Endo International PLC (NASDAQ:ENDP) last posted its quarterly earnings results on Thursday, July 31st. The company reported $1.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.88 by $0.18. The company had revenue of $719.00 million for the quarter, compared to the consensus estimate of $644.60 million. During the same quarter in the previous year, the company posted $1.42 earnings per share. The company’s revenue for the quarter was up .9% on a year-over-year basis. Analysts expect that Endo International PLC will post $4.04 EPS for the current fiscal year.

Endo International PLC, formerly Endo Health Solutions Inc is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.